Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Christina Schmidt et al.|Blood|2022Cited by 100
Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smearsJan‐Niklas Eckardt, Jan Moritz Middeke, Tim Schmittmann et al.|BMC Cancer|2022Cited by 75
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationJan Moritz Middeke, Johannes Schetelig, Min Fang et al.|Blood|2014Cited by 74
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestationsJan‐Niklas Eckardt, Jan Moritz Middeke, Friedrich Stölzel et al.|Journal of Hematology & Oncology|2022Cited by 58
Differential impact of <i>IDH1</i>/<i>2</i> mutational subclasses on outcome in adult AML: results from a large multicenter studyJan Moritz Middeke, Christian Thiede, Klaus H. Metzeler et al.|Blood Advances|2021Cited by 44